APNG as a prognostic marker in patients with glioblastoma

• Sigurd Fosmark,

  Affiliations Department of Pathology, Odense University Hospital, Odense, Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

  ⨯
• Sofie Hellwege,

  Affiliations Department of Pathology, Odense University Hospital, Odense, Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

  ⨯
• Rikke H. Dahlrot,

  Affiliation Department of Oncology, Odense University Hospital, Odense, Denmark

  ⨯
• Kristian L. Jensen,

  Affiliation DAKO Denmark A/S, Glostrup, Denmark

  ⨯
• Helene Derand,

  Affiliation DAKO Denmark A/S, Glostrup, Denmark

  ⨯
• Jesper Lohse,

  Affiliation DAKO Denmark A/S, Glostrup, Denmark

  ⨯
• Mia D. Sørensen,

  Affiliations Department of Pathology, Odense University Hospital, Odense, Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

  ⨯
• Steinbjørn Hansen,

  Affiliations Department of Clinical Research, University of Southern Denmark, Odense, Denmark, Department of Oncology, Odense University Hospital, Odense, Denmark

  ⨯
• Bjarne W. Kristensen

  * E-mail: bjarne.winther.kristensen@rsyd.dk

  Affiliations Department of Pathology, Odense University Hospital, Odense, Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark

  ⨯